Development and Initial Feasibility of a Hospital-Based Acceptance and Commitment Therapy Intervention to Improve Retention in Care for Out-of-Care Persons with HIV: Lessons Learned from an Open Pilot Trial

Lilian Dindo, Ethan Moitra, McKenzie K Roddy, Chelsea Ratcliff, Christine Markham, Thomas Giordano, Lilian Dindo, Ethan Moitra, McKenzie K Roddy, Chelsea Ratcliff, Christine Markham, Thomas Giordano

Abstract

Roughly 40% of persons with HIV (PWH) are not consistently involved in HIV care in the US. Finding out-of-care PWH is difficult, but hospitalization is common and presents an opportunity to re-engage PWH in outpatient care. The aims of this study were to (1) develop an Acceptance and Commitment Therapy (ACT)-based intervention for hospitalized, out-of-care PWH who endorse avoidance-coping to improve HIV treatment engagement; (2) examine the intervention’s initial feasibility and acceptability; and (3) to revise the study protocol (including the intervention), based on stakeholder feedback, in preparation for a randomized controlled trial (RCT) comparing ACT to treatment as usual. Therapists and HIV care experts developed a four-session ACT-based intervention to be delivered during hospitalization. Fifteen hospitalized patients with poorly controlled HIV enrolled in the open trial, eight completed four sessions, two completed three sessions, and seven provided qualitative feedback. Patients universally liked the intervention and the holistic approach to mental health and HIV care. Refinements included repeating key concepts, including representative graphics, and translating to Spanish. Among the patients who attended ≥3 ACT sessions, 5/10 attended a HIV-care follow-up visit and 5/7 who had labs had a viral load <20 2-months post-intervention. Next steps include conducting a randomized clinical trial exploring the impact of the refined intervention to treatment as usual on retention in care and viral load. ClinicalTrials.gov Identifier: NCT04481373.

Keywords: Acceptance and Commitment Therapy; HIV; hospital; retention.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Long term effects of avoidance coping.
Figure 2
Figure 2
Conceptual model.
Figure 3
Figure 3
Summary of procedures.
Figure 4
Figure 4
Consort diagram.

References

    1. Centers for Disease Control and Prevention: Understanding the HIV Care Continuum. published July 2019. [(accessed on 30 November 2019)]; Available online: .
    1. Bradley H., Hall H.I., Wolitski R.J., Van Handel M.M., Stone A.E., LaFlam M., Skarbinski J., Higa D.H., Prejean J., Frazier E.L., et al. Vital Signs: HIV diagnosis, care, and treatment among persons living with HIV—United States, 2011. MMWR Morb. Mortal. Wkly. Report. 2014;63:1113–1117.
    1. Marks G., Gardner L.I., Craw J., Crepaz N. Entry and retention in medical care among HIV-diagnosed persons: A meta-analysis. AIDS. 2010;24:2665–2678. doi: 10.1097/QAD.0b013e32833f4b1b.
    1. DHHS: Guidelines for the use of antiretroviral agents in HIVinfected adults and adolescents. Edited by Services HaH2016. Ann. Intern. Med. 1998;128:1079–1100. doi: 10.7326/0003-4819-128-12_Part_2-199806151-00003.
    1. Monitoring HIV Care in the United States: Indicators and Data Systems. Medicine Io.; Washington, DC, USA: 2012.
    1. Giordano T.P., Gifford A.L., White A.C., Jr., Suarez-Almazor M.E., Rabeneck L., Hartman C., Backus L.I., Mole L.A., Morgan R.O. Retention in care: A challenge to survival with HIV infection. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2007;44:1493–1499. doi: 10.1086/516778.
    1. Giordano T.P., White A.C., Jr., Sajja P., Graviss E.A., Arduino R.C., Adu-Oppong A., Lahart C.J., Visnegarwala F. Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. J. Acquir. Immune Defic. Syndr. 2003;32:399–405. doi: 10.1097/00126334-200304010-00009.
    1. HIV Surveillance Report 2018. Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services; Atlanta, Georgia: 2019. Prevention UCfDCa. HIV in the United States by Region; p. 29.
    1. Li Z., Purcell D.W., Sansom S.L., Hayes D., Hall H.I. Vital Signs: HIV Transmission Along the Continuum of Care—United States, 2016. MMWR Morb. Mortal. Wkly. Rep. 2018;68:267–272. doi: 10.15585/mmwr.mm6811e1.
    1. Zinski A., Westfall A.O., Gardner L.I., Giordano T.P., Wilson T.E., Drainoni M.L., Keruly J.C., Rodriguez A.E., Malitz F., Batey D.S., et al. The contribution of missed clinic visits to disparities in HIV viral load outcomes. Am. J. Public Health. 2015;105:2068–2075. doi: 10.2105/AJPH.2015.302695.
    1. Howe C.J., Napravnik S., Cole S.R., Kaufman J.S., Adimora A.A., Elston B., Eron J.J., Jr., Mugavero M.J. African American race and HIV virological suppression: Beyond disparities in clinic attendance. Am. J. Epidemiol. 2014;179:1484–1492. doi: 10.1093/aje/kwu069.
    1. Ford N., Shubber Z., Meintjes G., Grinsztejn B., Eholie S., Mills E.J., Davies M.A., Vitoria M., Penazzato M., Nsanzimana S., et al. Causes of hospital admission among people living with HIV worldwide: A systematic review and meta-analysis. Lancet HIV. 2015;2:e438–e444. doi: 10.1016/S2352-3018(15)00137-X.
    1. Metsch L.R., Bell C., Pereyra M., Cardenas G., Sullivan T., Rodriguez A., Gooden L., Khoury N., Kuper T., Brewer T., et al. Hospitalized HIV-infected patients in the era of highly active antiretroviral therapy. Am. J. Public Health. 2009;99:1045–1049. doi: 10.2105/AJPH.2008.139931.
    1. Berry S.A., Fleishman J.A., Moore R.D., Gebo K.A. Trends in reasons for hospitalization in a multisite United States cohort of persons living with HIV, 2001–2008. J. Acquir. Immune Defic. Syndr. 2012;59:368–375. doi: 10.1097/QAI.0b013e318246b862.
    1. Nijhawan A.E., Clark C., Kaplan R., Moore B., Halm E.A., Amarasingham R. An electronic medical record-based model to predict 30-day risk of readmission and death among HIV-infected inpatients. J. Acquir. Immune Defic. Syndr. 2012;61:349–358. doi: 10.1097/QAI.0b013e31826ebc83.
    1. Davy-Mendez T., Napravnik S., Wohl D.A., Durr A.L., Zakharova O., Farel C.E., Eron J.J. Hospitalization Rates and Outcomes among Persons Living with HIV in the Southeastern United States, 1996–2016. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2020;71:1616–1623. doi: 10.1093/cid/ciz1043.
    1. Hellinger F.J. Hospital use by persons with HIV in the 21st century: A 5-state study. Med. Care. 2016;54:639–644. doi: 10.1097/MLR.0000000000000526.
    1. Philbin M., Feaster D., Gooden L., Pan Y., Das M., Pati R., Armstrong W.S., del Rio C., Metsch L.R., McMahon D.K., et al. The North-South Divide: Substance Use Risk, Care Engagement and Viral Suppression Among Hospitalized HIV-Infected Patients in 11 U.S. Cities. Phoenix, AZ, College on Problems of Drug Dependence; 2015. Clin. Infect. Dis. 2019;68:146–149. doi: 10.1093/cid/ciy506.
    1. Del Rio C., Green S., Abrams C., Lennox J. From diagnosis to undetectable: The reality of HIV/AIDS care in the inner city; Proceedings of the 8th Conference on Retroviruses and Opportunistic Infections; Chicago, IL, USA. 4–8 February 2001; p. S21.
    1. Davila J.A., Hartman C., Cully J., Stanley M., Amico K.R., Soriano E., Minick S., May S.B., Giordano T.P. Feasibility of identifying out of care HIV-positive patients in a hospital setting and enrolling them in a retention intervention. HIV Clin. Trials. 2017;18:75–82. doi: 10.1080/15284336.2017.1287536.
    1. Metsch L.R., Feaster D.J., Gooden L., Matheson T., Stitzer M., Das M., Jain M.K., Rodriguez A.E., Armstrong W.S., Lucas G.M., et al. Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A randomized clinical trial. JAMA. 2016;316:156–170. doi: 10.1001/jama.2016.8914.
    1. Sharp J., Angert C.D., McConnell T., Wortley P., Pennisi E., Roland L., Mehta C.C., Armstrong W.S., Shah B., Colasanti J.A. Health Information Exchange: A Novel Re-linkage Intervention in an Urban Health System. Open Forum Infect. Dis. 2019;6:ofz402. doi: 10.1093/ofid/ofz402.
    1. Minick S.G., May S.B., Amico K.R., Cully J., Davila J.A., Kallen M.A., Giordano T.P. Participants’ perspectives on improving retention in HIV care after hospitalization: A post-study qualitative investigation of the MAPPS study. PLoS ONE. 2018;13:e0202917. doi: 10.1371/journal.pone.0202917.
    1. English K., May S.B., Davila J.A., Cully J.A., Dindo L., Amico K.R., Kallen M.A., Giordano T.P. Retention in Care and Viral Load Improvement After Discharge Among Hospitalized Out-of-Care People With HIV Infection: A Post Hoc Analysis of a Randomized Controlled Trial. Open Forum Infect. Dis. 2020;7:ofaa193. doi: 10.1093/ofid/ofaa193.
    1. Sayles J.N., Wong M.D., Kinsler J.J., Martins D., Cunningham W.E. The association of stigma with self-reported access to medical care and antiretroviral therapy adherence in persons living with HIV/AIDS. J. Gen. Intern. Med. 2009;24:1101–1108. doi: 10.1007/s11606-009-1068-8.
    1. Rueda S., Mitra S., Chen S., Gogolishvili D., Globerman J., Chambers L., Wilson M., Logie C.H., Shi Q., Morassaei S., et al. Examining the associations between HIV-related stigma and health outcomes in people living with HIV/AIDS: A series of meta-analyses. BMJ Open. 2016;6:e011453. doi: 10.1136/bmjopen-2016-011453.
    1. Marshall B.D., Operario D., Bryant K.J., Cook R.L., Edelman E.J., Gaither J.R., Gordon A.J., Kahler C.W., Maisto S.A., McGinnis K.A., et al. Drinking trajectories among HIV-infected men who have sex with men: A cohort study of United States veterans. Drug Alcohol Depend. 2015;148:69–76. doi: 10.1016/j.drugalcdep.2014.12.023.
    1. Orlando G., Meraviglia P., Cordier L., Meroni L., Landonio S., Giorgi R., Fasolo M., Faggion I., Riva A., Zambelli A., et al. Antiretroviral treatment and age-related comorbidities in a cohort of older HIV-infected patients. HIV Med. 2006;7:549–557. doi: 10.1111/j.1468-1293.2006.00420.x.
    1. Orlando M., Burnam M.A., Beckman R., Morton S.C., London A.S., Bing E.G., Fleishman J.A. Re-estimating the prevalence of psychiatric disorders in a nationally representative sample of persons receiving care for HIV: Results from the HIV Cost and Services Utilization Study. Int. J. Methods Psychiatr. Res. 2002;11:75–82. doi: 10.1002/mpr.125.
    1. Yehia B.R., Stewart L., Momplaisir F., Mody A., Holtzman C.W., Jacobs L.M., Hines J., Mounzer K., Glanz K., Metlay J.P., et al. Barriers and facilitators to patient retention in HIV care. BMC Infect. Dis. 2015;15:246. doi: 10.1186/s12879-015-0990-0.
    1. Wohl A.R., Galvan F.H., Myers H.F., Garland W., George S., Witt M., Cadden J., Operskalski E., Jordan W., Carpio F., et al. Do social support, stress, disclosure and stigma influence retention in HIV care for Latino and African American men who have sex with men and women? AIDS Behav. 2011;15:1098–1110. doi: 10.1007/s10461-010-9833-6.
    1. Michlig G.J., Westergaard R.P., Lam Y., Ahmadi A., Kirk G.D., Genz A., Keruly J., Hutton H., Surkan P.J. Avoidance, meaning and grief: Psychosocial factors influencing engagement in HIV care. AIDS Care. 2018;30:511–517. doi: 10.1080/09540121.2018.1425366.
    1. Cherenack E.M., Sikkema K.J., Watt M.H., Hansen N.B., Wilson P.A. Avoidant Coping Mediates the Relationship Between Self-Efficacy for HIV Disclosure and Depression Symptoms Among Men Who Have Sex with Men Newly Diagnosed with HIV. AIDS Behav. 2018;22:3130–3140. doi: 10.1007/s10461-018-2036-2.
    1. Martinez D.A., Goggin K., Catley D., Gerkovich M.M., Williams K., Wright J., Berkley-Patton J., MOTIV8 Do coping styles mediate the relationship between substance use and educational attainment and antiretroviral adherence? AIDS Behav. 2012;16:2319–2329. doi: 10.1007/s10461-012-0222-1.
    1. Earnshaw V.A., Bogart L.M., Laurenceau J.P., Chan B.T., Maughan-Brown B.G., Dietrich J.J., Courtney I., Tshabalala G., Orrell C., Gray G.E., et al. Internalized HIV stigma, ART initiation and HIV-1 RNA suppression in South Africa: Exploring avoidant coping as a longitudinal mediator. J. Int. AIDS Soc. 2018;21:e25198. doi: 10.1002/jia2.25198.
    1. Moitra E., Herbert J.D., Forman E.M. Acceptance-based behavior therapy to promote HIV medication adherence. AIDS Care. 2011;23:1660–1667. doi: 10.1080/09540121.2011.579945.
    1. Katz I.T., Bogart L.M., Dietrich J.J., Leslie H.H., Iyer H.S., Leone D., Magidson J.F., Earnshaw V.A., Courtney I., Tshabalala G., et al. Understanding the role of resilience resources, antiretroviral therapy initiation, and HIV-1 RNA suppression among people living with HIV in South Africa: A prospective cohort study. AIDS. 2019;33((Suppl. 1)):S71–S79. doi: 10.1097/QAD.0000000000002175.
    1. Moses E.B., Barlow D.H. A New Unified Treatment Approach for Emotional Disorders Based on Emotion Science. Curr. Dir. Psychol. Sci. 2006;15:146–150. doi: 10.1111/j.0963-7214.2006.00425.x.
    1. Hayes S.C., Strosahl K.D., Wilson K.G. Acceptance and Commitment Therapy: The Process and Practice of Mindful Change. 2nd ed. The Guilford Press; New York, NY, USA: 2012.
    1. Moitra E., Chan P.A., Stein M.D. Open Trial of an Acceptance-based Behavior Therapy Intervention to Engage Newly Diagnosed HIV Patients in Care: Rationale and Evidence of Feasibility and Acceptability. Behav. Modif. 2015;39:670–690. doi: 10.1177/0145445515590977.
    1. Moitra E., LaPlante A., Armstrong M.L., Chan P.A., Stein M.D. Pilot Randomized Controlled Trial of Acceptance-Based Behavior Therapy to Promote HIV Acceptance, HIV Disclosure, and Retention in Medical Care. Aids Behav. 2017;21:2641–2649. doi: 10.1007/s10461-017-1780-z.
    1. Office of Infectious Disease and HIV/AIDS Policy H: Ending the HIV Epidemic. [(accessed on 2 February 2021)];2020 Available online: .
    1. Fleishman J.A., Fogel B. Coping and depressive symptoms among people with AIDS. Health Psychol. Off. J. Div. Health Psychol. Am. Psychol. Assoc. 1994;13:156–169. doi: 10.1037/0278-6133.13.2.156.
    1. Henry J.D., Crawford J.R. The short-form version of the Depression Anxiety Stress Scales (DASS-21): Construct validity and normative data in a large non-clinical sample. Br. J. Clin. Psychol. 2005;44:227–239. doi: 10.1348/014466505X29657.
    1. Kalichman S.C., Simbayi L.C., Cloete A., Mthembu P.P., Mkhonta R.N., Ginindza T. Measuring AIDS stigmas in people living with HIV/AIDS: The Internalized AIDS-Related Stigma Scale. AIDS Care. 2009;21:87–93. doi: 10.1080/09540120802032627.
    1. Tsai A.C., Weiser S.D., Steward W.T., Mukiibi N.F., Kawuma A., Kembabazi A., Muzoora C., Hunt P.W., Martin J.N., Bangsberg D.R. Evidence for the reliability and validity of the internalized AIDS-related stigma scale in rural Uganda. AIDS Behavior. 2013;17:427–433. doi: 10.1007/s10461-012-0281-3.
    1. Pappin M., Wouters E., Booysen F.L. Anxiety and depression amongst patients enrolled in a public sector antiretroviral treatment programme in South Africa: A cross-sectional study. BMC Public Health. 2012;12:244. doi: 10.1186/1471-2458-12-244.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj